The Case for a Pregnancy-Specific Nicotine Policy
Abstract
AIMS
We aimed to evaluate the proposition that nicotine delivery by any means during pregnancy adversely affects the fetus and infant, review national policies on nicotine use in pregnancy across four high-income countries and propose a coherent pregnancy-specific nicotine policy framework.
METHODS
Clinical guidelines, public health policy documents and evidence-based recommendations on tobacco and nicotine use in pregnancy were reviewed.
RESULTS
Smoking in pregnancy is strongly associated with adverse perinatal outcomes. Similar but less consistent associations are reported with snus and vaping, supporting avoidance of nicotine in all forms. National policies vary: NZ and the UK adopt harm-reduction approaches, encouraging substitution with alternative nicotine products such as vaping, whereas the US and Sweden emphasise complete nicotine cessation. We propose a precautionary framework that recognises the mother-infant dyad as the unit of care; prioritises nicotine-free pregnancy; provides personalised cessation support for all pregnant women; reserves nicotine replacement therapy with clinical caution when behavioural support is insufficient; discourages vaping; and strengthens surveillance through early carbon monoxide monitoring and systematic recording of nicotine exposure.
CONCLUSION
This framework provides a coherent pregnancy-specific nicotine policy centred on cessation as the mechanism of protection for the mother-infant dyad, with the aim of improving pregnancy…
Read the paper
Related studies
- Tobacco and COPD: presenting the World Health Organization (WHO) Tobacco Knowledge Summary
- Comparative effects of e-cigarette smoking on periodontal status, salivary pH, and cotinine levels
- Association between exposure to environmental pollutants and increased oral health risks, a comprehensive review
- Influence of gestational window on offspring vascular health in rodents with in utero exposure to electronic cigarettes
- Natural products as kinase inhibitors in lung cancer: molecular mechanisms, therapeutic potential, and clinical trials
- Nicotine in electronic cigarettes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.